Almenoff June Sherie's Form 4/A amendment
AmendedTenax Therapeutics, Inc. (TENX) · filed Nov 20, 2025
- Accession no.
- 0001492647-25-000004
- Filed
- Nov 20, 2025
- Trade date
- Nov 17-18, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 19, 2025
This filing lists 2 non-derivative transactions. Open-market purchases total $15.0K. It was filed 3 days after the trade.
This amendment replaces 0001492647-25-000003 (filed Nov 19, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Almenoff June SherieCIK 0001492647 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | PPurchaseAcquired | +93 | $7.15 | +$664.95 | 93 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +1,900 | $7.52F2 | +$14,288 | 1,993 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- F2
This transaction was executed in multiple trades at prices ranging from $7.45 to $7.70. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Remarks
This amendment is being filed to correct the ownership form of the 1,993 shares acquired, which was inadvertently reported on the original filing as direct. Columns 6 and 7 have been adjusted to reflect this correction.